Protagenic Therapeutics
NASDAQ: PTIX
Healthcare
Biotechnology
Rank
#45940
Market Cap
1.56 M
Volume
479,509
Price
2.90
Change (%)
7.48%
Country or region
United States
United States
Protagenic Therapeutics Stock Split History Overview
This company has undergone a total of 5 stock splits throughout its history. 5 reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 5, 2025 with a ratio of 1-for-14. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Protagenic Therapeutics (NASDAQ: PTIX) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 5, 2025 | 1:14 | x0.071428575 | x8.919635E-10 | Reverse |
| March 23, 2023 | 1:4 | x0.25 | x1.2487488E-08 | Reverse |
| July 27, 2016 | 1:16666.7 | x5.9999882E-05 | x4.9949954E-08 | Reverse |
| December 3, 2010 | 1:4 | x0.25 | x0.00083250087 | Reverse |
| May 3, 2007 | 1:300.3 | x0.0033300035 | x0.0033300035 | Reverse |
Frequently Asked Questions
If Protagenic Therapeutics (stock symbol: NASDAQ: PTIX) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-14) that occurred on May 5, 2025.
Protagenic Therapeutics (stock symbol: NASDAQ: PTIX) has undergone a total of 5 stock splits. The most recent split occurred on May 5, 2025. One share bought prior to the first split on May 3, 2007 would now equal 0.00 shares.
Protagenic Therapeutics (stock symbol: NASDAQ: PTIX) has undergone 5 stock splits in its history. The most recent split, a 1-for-300.3 split, occurred on May 5, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.